These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6171602)

  • 21. Enhanced immunogenicity of the cultured rat fibrosarcoma KMT-17 by cultivation in a low concentration of fetal calf serum.
    Chiba I; Oikawa T; Naiki M; Takimoto M; Miyoshi I; Mizuno S; Yamashina K; Yamagiwa S; Kobayashi H
    Cancer Res; 1987 Apr; 47(7):1815-9. PubMed ID: 3815375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
    Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
    Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells.
    Hollingsworth MA; Evans DL
    J Natl Cancer Inst; 1984 Jun; 72(6):1357-63. PubMed ID: 6233443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of tumor antigen expression and inhibition of pulmonary metastasis of rat fibrosarcoma cells by local radiotherapy.
    Shibata T; Hosokawa M; Micallef M; Chiba I; Mizukoshi T; Kato M; Takeichi N; Kobayashi H
    Anticancer Res; 1997; 17(1A):317-22. PubMed ID: 9066671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel.
    Morikawa K; Okada F; Hosokawa M; Kobayashi H
    Cancer Res; 1987 Jan; 47(1):37-41. PubMed ID: 3491675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonspecific inhibition of in vivo tumor growth by allo-sensitized lymphocytes - requirement of radio-sensitive T-lymphocytes.
    Sendo F
    Hokkaido Igaku Zasshi; 1982 Jan; 57(1):27-35. PubMed ID: 6978834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
    Mizushima Y; Koga Y; Yuhki N; Kobayashi H
    Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of tumor associated antigen expression during the regression phase of xenogenized tumor cell growth in vivo.
    Shibata T; Micallef M; Chiba I; Arisue M; Hosokawa M; Okada F; Takeichi N; Kobayashi H
    Anticancer Res; 1997; 17(3C):2135-40. PubMed ID: 9216677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice.
    Barsoum AL; Coggin JH
    J Biol Response Mod; 1989 Dec; 8(6):579-92. PubMed ID: 2600602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of natural anti-tumor antibody carrying a cross-reactive idiotype in the rat].
    Natori T
    Hokkaido Igaku Zasshi; 1983 Jul; 58(4):420-8. PubMed ID: 6629313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system.
    Ito M; Suzuki E; Naiki M; Sendo F; Arai S
    Int J Cancer; 1984 Nov; 34(5):689-97. PubMed ID: 6209227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo.
    Roberts LK; Spellman CW; Warner NL
    J Immunol; 1983 Jul; 131(1):514-9. PubMed ID: 6223081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of antigenic expression on rat tumor cells after their transplantation.
    Gotohda E; Sendo F; Nakayama M; Hosokawa M; Kawamura T
    J Natl Cancer Inst; 1975 Nov; 55(5):1079-83. PubMed ID: 1206734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.